Works matching IS 14611457 AND DT 2019 AND VI 22 AND IP 10

Results: 7

(R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 675, doi. 10.1093/ijnp/pyz048
By:
- Zhang, Jiancheng;
- Qu, Youge;
- Chang, Lijia;
- Pu, Yaoyu;
- Hashimoto, Kenji
Publication type:
Article
Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 631, doi. 10.1093/ijnp/pyz047
By:
- Dornbierer, D A;
- Boxler, M;
- Voegel, C D;
- Stucky, B;
- Steuer, A E;
- Binz, T M;
- Baumgartner, M R;
- Baur, D M;
- Quednow, B B;
- Kraemer, T;
- Seifritz, E;
- Landolt, H P;
- Bosch, O G
Publication type:
Article
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M<sub>1</sub> Receptor in Some Participants With Schizophrenia.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 640, doi. 10.1093/ijnp/pyz045
By:
- Hopper, Shaun;
- Pavey, Geoffrey Mark;
- Gogos, Andrea;
- Dean, Brian
Publication type:
Article
Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 651, doi. 10.1093/ijnp/pyz043
By:
- Mallet, Jasmina;
- Gorwood, Philip;
- Strat, Yann Le;
- Dubertret, Caroline
Publication type:
Article
(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 665, doi. 10.1093/ijnp/pyz041
By:
- Ago, Yukio;
- Tanabe, Wataru;
- Higuchi, Momoko;
- Tsukada, Shinji;
- Tanaka, Tatsunori;
- Yamaguchi, Takumi;
- Igarashi, Hisato;
- Yokoyama, Rei;
- Seiriki, Kaoru;
- Kasai, Atsushi;
- Nakazawa, Takanobu;
- Nakagawa, Shinsaku;
- Hashimoto, Kenji;
- Hashimoto, Hitoshi
Publication type:
Article
The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder.
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 609, doi. 10.1093/ijnp/pyz038
By:
- Huang, Chun-Jen;
- Lin, Ching-Hua;
- Wu, Jyh-I;
- Yang, Wei-Cheng
Publication type:
Article
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Published in:
International Journal of Neuropsychopharmacology, 2019, v. 22, n. 10, p. 616, doi. 10.1093/ijnp/pyz039
By:
- Fedgchin, Maggie;
- Trivedi, Madhukar;
- Daly, Ella J;
- Melkote, Rama;
- Lane, Rosanne;
- Lim, Pilar;
- Vitagliano, Dawn;
- Blier, Pierre;
- Fava, Maurizio;
- Liebowitz, Michael;
- Ravindran, Arun;
- Gaillard, Raphael;
- Ameele, Hans Van Den;
- Preskorn, Sheldon;
- Manji, Husseini;
- Hough, David;
- Drevets, Wayne C;
- Singh, Jaskaran B
Publication type:
Article

Works matching IS 14611457 AND DT 2019 AND VI 22 AND IP 10

(R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress.

Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.

Widespread Changes in Positive Allosteric Modulation of the Muscarinic M<sub>1</sub> Receptor in Some Participants With Schizophrenia.

Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review.

(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism.

The Relationship Between Depression Symptoms and Anxiety Symptoms During Acute ECT for Patients With Major Depressive Disorder.

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).